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mirBaseescence induction exist including telomere attrition, oxidative stress, oncogene
expression and DNA damage signalling. The regulation of the cellular changes required to respond to these
stimuli and create the complex senescent cell phenotype has many different mechanisms. MiRNAs present
one mechanism by which genes with diverse functions on multiple pathways can be simultaneously
regulated. In this study we investigated 12 miRNAs previously identiﬁed as senescence regulators. Using
pathway analysis of their target genes we tested the relevance of miRNA regulation in the induction of
senescence. Our analysis highlighted the potential of these senescence-associated miRNAs (SA-miRNAs) to
regulate the cell cycle, cytoskeletal remodelling and proliferation signalling logically required to create a
senescent cell. The reanalysis of publicly available gene expression data from studies exploring different
senescence stimuli also revealed their potential to regulate core senescence processes, regardless of stimuli.
We also identiﬁed stimulus speciﬁc apoptosis survival pathways theoretically regulated by the SA-miRNAs.
Furthermore the observation that miR-499 and miR-34c had the potential to regulate all 4 of the senescence
induction types we studied highlights their future potential as novel drug targets for senescence induction.
© 2009 Elsevier B.V. All rights reserved.1. Cellular senescence
The irreversible cell-cycle arrest known as senescence can be
induced by a number of factors including: telomere attrition, known
as replicative senescence [1]; oxidative stress [2]; oncogene expres-
sion [3] and DNA damage signalling [4]. Senescence is involved in the
regulation of cellular aging and tissue maintenance and acts as a
barrier to immortality and tumourigenesis. Individual regulatory
mechanisms promoting the establishment of senescence have been
characterised, including for example gene expression changes in p16,
p53 and p21 [5]; chromatin silencing of E2F target genes [6] and
protein phosphorylation by DNA damage checkpoint kinases [7]. All of
these molecular changes occur in the larger cellular context and result
in changes to pathways regulating different cellular processes, as
summarised in Fig. 1.
Complex cell phenotypes such as senescence are unlikely to result
simply from a change in a single pathway but instead from
cooperative changes in multiple systems. The complete network of
underlying pathways resulting in cellular senescence is currently
unclear. Investigations of mechanisms by which senescence is
regulated continue to present novel pathways and regulatoryh).
ll rights reserved.molecules involved in the process. MicroRNAs (miRNAs) present a
mechanism bywhich genes involved in a variety of different signalling
pathways can be regulated simultaneously. They therefore present a
further level of molecular interactions by which senescence may be
induced.
1.1. MiRNAs as potential regulators of cellular senescence
Of themany ways to regulate gene product expression, miRNAs are
relatively poorly understood. These short non-coding molecules
ranging in size from 19 to 22 nucleotides are highly conserved and
regulate protein expression through interactions with the 3′ untrans-
lated region (UTR) of mRNA [8,9]. The binding of amiRNA to the 3′UTR
causes inhibition of translation through steric hindrance or degrada-
tion of the mRNA, depending on the degree of complementarity
between the two sequences [10]. The ability of miRNAs to regulate a
variety of target genes allows them to induce changes in multiple
pathways and processes such as development [11], apoptosis,
proliferation and differentiation [12]. MiRNAs could therefore facil-
itate the complex cellular changes required to establish the senescent
phenotype. Identiﬁcation of the mRNA sequences that miRNAs
regulate is mainly derived using bioinformatics techniques. The ability
of each miRNA to target genes is based on sequence complementarity
to 3′UTRs of known mRNAs. The mirBase sequence database is the
main repository formiRNA sequence and target information and (as of
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the potential to regulate on average 1000 gene targets [13–15]. It is
this large number of potential targets across different biological
pathways that give miRNAs the power to potentially induce complex
cell phenotypes, like senescence.
2. Twelve senescence associated miRNAs with experimental
evidence for regulation of senescence
Although the gene targets of miRNAs can be identiﬁed
theoretically by computational algorithms, it is unclear exactly
which potential target genes they modulate and to what extent this
affects the associated functions of these genes. The identiﬁcation of
miRNAs with the ability to regulate a complex phenotype, like
senescence, is therefore not possible using purely bioinformatic
techniques. For this reason we performed database searches of the
terms miRNA and senescence, using pubmed and ISI web of
knowledge (accessed 18 Nov 2008), to identify miRNAs with
experimental evidence of involvement in senescence. The literature
search highlighted 6 studies with direct evidence for regulation of
senescence by miRNAs. Two main approaches were used in these
studies: microarray based and comprehensive functional genomics;
and the investigation of candidate senescence genes and the
miRNAs regulating them. The 6 studies highlight a total of 12Fig. 1. The establishment of a complex cell phenotype, such as senescence, requires the in
and processes.senescence-associated miRNAs (SA-miRNAs). Each miRNA has the
ability to bind between 953 and 2351 sites on mRNA 3′ UTRs (see
Table 1) and in addition some 3′UTRs potentially have multiple
complementary sites for a given miRNA. To add to the complexity, in
reality this set of miRNAs may be a subset of the total number of
miRNAs that play a role in senescence.
Looking at the individual SA-miRNAs we can see that some
miRNAs have more support for their roles in senescence than others
(Table 1). The evidence for a regulatory role of the miR-34 family of
miRNAs in senescence is growing and has stemmed from the
investigation of p53 and its role in senescence. A number of studies
have identiﬁed the miR-34 family, particularly miR-34a, as down-
stream effectors of p53 involved in the cell cycle [16]. Recent
research has found that up-regulation of miR-34a in various cancer
cell lines leads to cell cycle arrest, increased expression of β-
galactosidase [17] and down-regulation of E2F family target genes
[18]. Furthermore, drug treatment of various cancer cell lines with
the MDM2 inhibiting drug Nutlin-3, leading to p53 activation,
induced up-regulation of primarily miR-34a and later miR-34b and
miR-34c [19]. Reports of a pro-apoptotic effect induced by miR-34a
[20,21] may demonstrate that its expression alone is not responsible
for senescence.
The potential role of hsa-miR-20a in senescence regulation was
discovered through investigation of the candidate senescenceteraction of many regulatory mechanisms leading to changes in individual pathways
Table 1
Senescence associated miRNAs from the literature and the number of computationally
derived mRNA 3′ untranslated regions each can target
Number Senescence
Associated
miRNA
Number of predicted
complementary sites
in the transcriptome
References
1 hsa-let-7f 1018 [25]Wagner et al., 2008
2 hsa-miR-499 2157 [25]Wagner et al., 2008
3 hsa-miR-373 1057 [26]Voorhoeve et al., 2006
4 hsa-miR-372 953 [26]Voorhoeve et al., 2006
5 hsa-miR-371 2205 [25]Wagner et al., 2008
6 hsa-miR-369-5P 1107 [25]Wagner et al., 2008
7 hsa-miR-34c 2351 [19]Kumamoto et al.,2008
8 hsa-miR-34b 1086 [19]Kumamoto et al.,2008
9 hsa-miR-34a 1296 [17–19]Tazawa et al., 2007,
He et al., 2007,
Kumamoto et al.,2008
A hsa-miR-29c 1199 [25]Wagner et al., 2008
B hsa-miR-217 993 [25]Wagner et al., 2008
C hsa-miR-20a 1275 [22]Poliseno et al., 2008
(Note some mRNAs may contain multiple binding sites.) Numbering denotes the
thermometer number representing particular miRNA's targets on Figs. 2–4.
Table 2
The top 5 pathways regulated by all 12 SA-miRNAs with the percentage of the map that
consists of SA-miRNA gene targets
Pathway map % of objects on the map
regulated by SA-miRNAs
1 The role of TGF and WNT in cytoskeletal
remodelling
44% (49/111)
2 Cytoskeletal remodelling general process 42% (43/102)
3 Cell cycle: the start of DNA replication in
early S-phase
59% (19/32)
4 Regulation of transcription in the
CREB pathway
50% (21/42)
5 Development EGFR signalling via
small GTPases
41% (13/32)
Gene target lists for each SA-miRNA were input to Metacore and the pathway maps
which were commonly regulated were examined. Pathways are ordered by the number
of SA-miRNA targets on each map. The presence of 4 regulatory pathways involving
different aspects of cellular signalling and only one cell cycle pathway shows that there
is more to senescence than just cell cycle regulation. SA-miRNAs therefore present a
mechanism by which a variety of the required cellular pathway changes could be
regulated.
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MDM2 inhibitor p19ARF [23,24]. The overexpression of miR-20a in
mouse embryonic ﬁbroblasts induced senescence by lowering LRF
protein levels and in turn increasing p19ARF levels. The fact that
investigation of two different senescence-associated genes, p53 and
LRF, yields different SA-miRNAs may be a reﬂection of the range of
signalling pathway changes that these molecules contribute to the
induction of the senescent phenotype.
Genome-wide analysis of changes in miRNA expression or
investigations of those miRNAs that allow senescence bypass are
alternative approaches that have been used in SA-miRNA identiﬁca-
tion. The use of microarrays identiﬁed miRNAs hsa-miR-371, hsa-miR-
369-5p, hsa-miR-29c, hsa-miR-499 and hsa-let-7f as signiﬁcantly up-
regulated in senescent human mesenchymal stem cells (hMSCs)
when compared to early passage hMSCs [25]. MiRNA hsa-miR-271
was also seen to be signiﬁcantly up-regulated by this study but overall
had very low expression levels. These varying levels of miRNA
expression may suggest different requirements for alterations in
their target gene pathways.
MiR-372 and miR-373 were identiﬁed as miRNAs whose expres-
sion was able to bypass RAS-induced senescence in the presence of
wild-type p53 [26]. The expression of these miRNAs would therefore
not be conducive to senescence andwe include them in our analysis as
examples of miRNAs whose targets may increase in expression during
senescence.
These reports provide experimental evidence for the molecular
mechanisms by which miRNAs may act in the context of
senescence. Recent reports of the regulatory effects of miRNAs
miR-17-5P and miR-24 on senescence regulators p21 and p16, may
offer further miRNAs with a role in senescence [27,28]. However,
lack of β-galactosidase and γH2AX analysis or the expected
alterations to senescence induction prevent us from being
completely clear whether these miRNAs play a direct role in
senescence. For this reason we did not include miR-17-5P or miR-
24 in our SA-miRNA cohort. By examining the biological pathways
that the 12 SA-miRNAs named in Table 1 can theoretically regulate,
we aim to gain a greater understanding of the biological changes
that these miRNAs could create that potentially lead a cell into
senescence.
2.1. Pathway mapping of senescence associated miRNA targets shows
cell cytoskeletal, cell cycle and proliferation regulation potential
By mapping the signalling pathways regulated by the SA-miRNAs
we aimed to better understand the biological mechanisms by whichthey can cooperate to create the complex senescence phenotype.
The free, publicly available Sanger miRNA database contains a
registry of computationally calculated gene targets for each known
miRNA. We downloaded (25 Aug 2008) and queried the current
version of the database (mirBase targets v5) using Microsoft Access,
in order to generate lists of theoretical gene targets for the 12 SA-
miRNAs. As the computational method of assigning gene targets to
miRNAs cannot assess the level of complementarity required for a
biological effect, we decided to include all theoretical targets in our
analysis.
The signalling pathways and processes that these gene targets
are involved in were explored using the systems biology tool
Metacore from Genego (Genego Inc, St Joseph, MI). This database of
known molecular interactions, pathways and processes manually
curated from published data allows the user to visualise known
biological systems within their data. Input of the SA-miRNA target
gene lists into the Metacore database allowed us to explore the
potential biological implications of their regulation during the
induction of senescence.
The top 5 pathways regulated by the SA-miRNAs are shown in
Table 2. Two of these maps are involved in cytoskeletal remodelling
and are highly saturated with gene targets of the SA-miRNAs (Fig. 2).
Senescent cells are seen to undergo changes in morphology, becoming
large and ﬂattened [29], which would require signiﬁcant cytoskeletal
remodelling. Such widespread cellular modiﬁcations would be
associated with the alteration of many different pathways and
processes that all contribute to the maintenance of the actin
cytoskeleton. Due to their ability to bind a number of different gene
targets miRNAs provide a mechanism by which such widespread
changes could be induced.
Changes in the processes involved in DNA synthesis in early S-
phase are also potentially regulated by the SA-miRNAs (Fig. 3). Of
the objects on this map 59% are potentially regulated by the SA-
miRNAs and in particular members of the MCM and ORC
complexes. The ORC and MCM complexes are responsible for the
initiation of DNA replication by assembly of the pre-replication
complexes and ensure that the process only occurs once during the
cell cycle [30]. Recently the ORC complex was reported to be able
to interact with the telomere binding protein TRF2 and affect
telomere homeostasis [31]. Replicative senescence relies on the
shortening of telomeres to induce a DNA damage checkpoint
response that blocks their progression into S-phase [7]. Since
senescence involves irreversible cell cycle arrest, SA-miRNA
regulation of cell cycle mechanisms strengthens their possible
role in senescence regulation.
Fig. 2. SA-miRNA regulation of the cytoskeletal remodelling and the role of TGF and WNT biological pathway map. Red thermometers show an object that can be regulated by a SA-
miRNAwith thermometer numbering corresponding to that seen in Table 1. Multiple thermometers denote that the object is a target of multiple SA-miRNAs. Green arrows represent
positive, red negative and grey unspeciﬁed interactions. Boxes on lines denote the type of regulation where P=phosphorylation; B=binding; Tr=transcriptional regulation,
Cm=covalent modiﬁcation, T=transformation and Z=catalysis.
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miRNAs (Fig. 4). CREB is a known regulator of cellular growth and
proliferation through its transcriptional regulation of genes such as
the oncogene c-fos [32] and regulators of the cell cycle such as cyclin
D1 [33] and cyclin A [34]. Alteration of molecules regulating CREB by
SA-miRNAs would therefore confer another mechanism to alter the
cell growth and proliferation pathways towards a senescent state.The regulation of EGFR and its proliferative signalling is not
conducive to a senescent cellular environment. Consistent with this,
EGFR is repressed at the chromatin level during senescence [6] and is
shown to be potentially regulated by the 12 SA-miRNAs (Table 2). The
ability of SA-miRNAs to further repress these signals provides a cell
entering senescence another regulatory mechanism by which to
ensure their silencing.
Fig. 3. SA-miRNA regulation of Cell cycle and DNA replication in early S phase biological map. Red thermometers show an object that can be regulated by a SA-miRNA with
thermometer numbering corresponding to that seen in Table 1. Multiple thermometers denote that the object is a target of multiple SA-miRNAs. Green arrows represent positive, red
negative and grey unspeciﬁed interactions. Boxes on lines denote the type of regulation where P=phosphorylation; B=binding; Tr=transcriptional regulation, Cm=covalent
modiﬁcation, T=transformation and Z=catalysis.
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miRNAs are potentially regulating many of the necessary steps
required to create a fully senescent cell, from changes in the cellular
cytoskeleton to alteration of multiple pathways regulating cell cycle
and proliferation signals. Their potential to act as master regulators ofsenescence could be a prospective source of novel drug targets and
biomarkers. Senescence can be stimulated by more than one
mechanism however, including induction by telomere attrition
(replicative senescence), oncogenes, drugs and cellular stress. It
remains unclear whether the same pathway alterations and miRNAs
Fig. 4. SA-miRNA regulation of transcription and the CREB pathway biological map. Red thermometers show an object that can be regulated by a SA-miRNA with thermometer
numbering corresponding to that seen in Table 1. Multiple thermometers denote that the object is a target of multiple SA-miRNAs. Green arrows represent positive, red negative and
grey unspeciﬁed interactions. Boxes on lines denote the type of regulation where P=phosphorylation; B=binding; Tr=transcriptional regulation, Cm=covalent modiﬁcation,
T=transformation and Z=catalysis.
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takes a different route to the same endpoint of a senescent cell, as
depicted in Fig. 5.
3. Investigation of SA-miRNA regulation of different senescence
stimuli
In order to investigate the potential of SA-miRNAs to regulate the
different senescence stimuli we returned to the literature. Usingpreviously published data we queried differentially expressed gene
lists from replicative senescence in hMSCs [25], drug induced
replicative senescence by a telomerase inhibitor [35], cellular stress
by Ethanol or tert-butylhydroperoxide exposure [2] and oncogene
induced senescence by BRAFE600 [3].
Each of the datasets queried showed some potential to be
regulated by the SA-miRNAs as shown in Table 3. Using the results
of these 4 analyses, we explored the potential of SA-miRNAs to
regulate pathways with gene expression changes for each stimulus.
Fig. 5. Potential mechanisms of miRNA regulation in senescence and their potential. A
small subset of miRNAs, such as the 12 SA-miRNAs that we have identiﬁed, may be
acting as master regulators of the senescent phenotype. However it is also possible that
individual types of senescence induction may require different miRNAs to create the
same cellular changes due to the different stimuli and therefore signalling pathways
involved. Overlaps in the biological pathways or miRNAs could therefore be utilised to
discover novel drug targets for senescence induction.
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pathways between stimuli were also investigated.
3.1. Pathways regulated by SA-miRNAs during replicative senescence
show increased cell survival and decreased cell cycle signalling
By reanalysing the publicly available gene expression data from
the study by Wagner et al., we examined the pathways during
replicative senescence that could be regulated by SA-miRNAs
(Table 4A) [25]. Gene lists of 2 fold or more changes in expression
between early and late passage hMSCs were constructed. Filtering
of these lists to only those genes theoretically regulated by the SA-
miRNAs led to the construction of 2 lists: 85 gene targets with
increased expression and 49 gene targets with decreased expres-
sion in late passage compared to early passage hMSCs. The
pathways associated with each gene list were then individually
explored using Metacore.
Looking initially at the pathways that have gene targets with
increased expression in Table 4A, we see that 3 of the 5 maps on the
list are involved with apoptosis and survival through the FAS and
TNFR1 signalling pathways or in a p53 dependent manner. In all 3maps the only molecules that the SA-miRNAs are regulating are BRE
and c-FLIP. BRE is known to suppress the apoptotic pathways through
binding and inhibition of the FAS receptor [36] and the TNF-alpha
receptor [37]. C-FLIP is a potent inhibitor of apoptosis through its
binding and resulting inhibition of the adaptor protein FADD [38].
Although the SA-miRNAs are only regulating 2 molecules involved in
the survival and apoptosis signalling pathways, regulation of the
absolute levels and timing of such signals may be one of the
mechanisms by which the SA-miRNAs ensure the cells enter
senescence rather than apoptosis.
The second most signiﬁcant pathway with increases in gene
expression during replicative senescence is cytoskeletal remodelling
centering on the role of intermediary ﬁlaments. As discussed
previously, changes in the cellular morphology of senescent cells
would require signiﬁcant changes to the cytoskeleton of the cell.
Increases in expression of key genes regulating many of these
processes would therefore be required. The SA-miRNAs provide one
potential mechanism by which these changes could be regulated.
Changes to the immune response and the IL1 signalling pathway
during replicative senescence are also potentially regulated by the SA-
miRNAs. The concept of the involvement of IL1 and other pro-
inﬂammatory networks in the induction of senescence is concurrent
with current ﬁndings [39–41]. Therefore the ability of SA-miRNAs to
regulate this pathway demonstrates a further mechanism by which
they could induce senescence.
The regulation of cellular survival, pro-inﬂammatory and cytos-
keletal remodelling cellular processes would all logically be required
to create the senescent cell phenotype. These processes can
theoretically be regulated by the SA-miRNAs, during replicative
senescence, showing that they have the potential to regulate the
absolute levels and timings of these complex signalling cascades to
create a senescent cell.
However, these are not the only pathways that the SA-miRNAs can
regulate during this process. Four out of the 5 pathways that contain
SA-miRNA gene targets with decreases in expression are involved in
various aspects of cell cycle regulation (Table 4A). These include DNA
replication in early S-phase and the roles of APC, the SCF complex and
ESR1. Regulation of keymolecules in the multiple processes governing
the cell cycle during senescence induction is critical. The SA-miRNAs
regulate a subset of molecules (CDK2, EMI1, Cyclin B, SKP2, and
CDC18L) that are involved in regulation of these multiple cell cycle
pathways. This allows the SA-miRNAs to affect the cell cycle regulatory
process as whole rather than at just one checkpoint or stage. The 12
SA-miRNAs that we have highlighted therefore exemplify the
potential of miRNAs to play a regulatory role in this aspect of
replicative senescence.
The remaining pathway containing gene targets down-regulated
during replicative senescence is involved in dCTP/dUTP metabo-
lism. Since senescent cells are no longer cycling, changes in
metabolism will follow. SA-miRNAs may only be regulating a small
part of cellular metabolism, the metabolism of 2 nucleotide units,
however these metabolic changes may have far reaching effects.
Furthermore, changes in dATP, ATP and TTP metabolism are seen
further down in the list of pathways, 6, 7 and 9 respectively, which
are not discussed here. It may therefore be the case that the SA-
miRNAs are able to regulate the changes in metabolism required to
establish senescence or that only changes to a few molecules or
processes are required.
Changes in gene expression during the establishment of replicative
senescence in hMSCs are potentially being regulated by the SA-
miRNAs. We have observed that the SA-miRNAs targeted down-
regulation of cell cycle pathways and increased signalling by pathways
involved in cytoskeletal remodelling and apoptosis survival. The
ability of a relatively small number of SA-miRNAs to differentially
regulate such diverse changes demonstrates their potential in the
induction of complex cellular phenotypes.
Table 3
Regulation of gene expression signatures of different types of senescence induction
SA-miRNA Replicative senescence Drug induced replicative
senescence
Oncogene induced senescence Stress induced senescence
Up 85
target genes
Down 49
target genes
Up 76 target genes Down 49
target genes
7 target genes ETOH up 10
target genes
EtOH down 6
target genes
tBHP up 6
target genes
tBHP down 6
target genes
miRNA miRNA miRNA miRNA miRNA miRNA miRNA miRNA miRNA
hsa-let-7f ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-20a ✓ ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-217 ✓ ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-29c ✓ ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-34a ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-34b ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-34c ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-369-5P ✓ ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-371 ✓ ✓ ✓ ✓ ✓ ✓ ✓
hsa-miR-372 ✓ ✓ ✓ ✓
hsa-miR-373 ✓ ✓ ✓ ✓
hsa-miR-499 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Ticks represent the ability of that SA-miRNA to theoretically regulate one or more genes within the signature. All four senescence induction signatures are regulated by at least 5 SA-
miRNAs. These differences in SA-miRNA regulation may represent the differing need for regulation of SA-miRNA target genes by different stimuli. The regulation of all of the
senescent signatures studied bymicroRNAs hsa-miR-499 and hsa-miR-34c may demonstrate their potential as regulators of core senescence genes required by all senescence stimuli.
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increased cell survival and decreased cell cycle signalling
Replicative senescence results from the shortening of telomeres
during each round of the cell cycle [1]. Many cancer cells reactivate the
enzyme telomerase, which has the ability to maintain telomeres and
therefore overcome this barrier to tumourigenesis [42]. Application of
a drug that inhibits telomerase would, in theory, activate the cells'
natural senescence pathways, potentially including the actions of the
SA-miRNAs. To explore this hypothesis we interrogated the differen-
tially expressed genes published by Damm et al. for potential SA-
miRNA regulation [35].
Damm et al. investigated senescence resulting from treatment of
lung carcinoma cells with the telomerase inhibitor BIBR1532. WeTable 4
Top 5 biological pathway maps that contain SA-miRNA gene targets shown in order of p-va
A Replicative senescence
85 upregulated SA-miRNA gene targets
SA-miRNA Pathway maps % Regulated by
SA-miRNAs
p-value
1 Apoptosis and survival p53-dependent 9% (2/29) 9.58E−03
2 Cytoskeletal remodelling keratin
ﬁlamentsKeratin Filaments
6% (2/36) 1.45E−02
3 Immune response IL1 signalling
pathway
5% (2/37) 1.53E−02
4 Apoptosis and survival FAS signalling
cascades
5% (2/43) 2.04E−02
5 Apoptosis and survival TNFR1 signalling
pathway
5% (2/43) 2.04E−02
B Drug induced replicative senescenceReplicative Senescence
49 Upregulated SA-miRNA gene targets
SA-miRNA Pathway maps % Regulated by
SA-miRNAs
p-value
1 Signal transduction PTEN pathway 11% (5/46) 6.52E−07
2 Development EGFR signalling via
small GTPases
14% (4/28) 3.13E−06
3 Signal Transduction Activin A signalling
regulation
14% (4/28) 3.13E−06
4 Transcription role of AP1 in regulation
of cellular metabolism
10% (4/42) 1.65E−05
5 Development ERBB-family signalling 9% (4/43) 1.81E−05
Wagner et al. microarray data were reanalysed and all genes with a 2 fold or more differen
ﬁltered selecting only gene targets of the 12 SA-miRNAS and biological pathways maps ana
Damm et al. published differentially expressed gene signatures which were ﬁltered selectin
Metacore from Genego.ﬁltered the published genes lists to include only those genes regulated
by the 12 SA-miRNAs. This resulted in a list of 76 down-regulated SA-
miRNA gene targets and 49 up-regulated gene targets (Table 4B).
Pathway analysis was then performed to investigate the potential
effects of SA-miRNA regulation in drug induced replicative
senescence.
As seen previously during the analysis of replicative senescence,
the pathways associated with gene targets showing increased
expression involve a variety of different cellular mechanisms. Two of
these pathways are involved in the regulation of cellular signalling by
the molecules PTEN and Activin A. The dual speciﬁcity phosphatase
PTEN is a tumour suppressor gene and regulates cellular proliferation
and survival through its ability to bind p53 in the nucleus [43]. Activin
A is a member of the TGFβ superfamily and is involved in thelue
49 downregulated SA-miRNA gene targets
Pathway maps % Regulated by
SA-miRNAs
p-value
Cell cycle role of APC in cell cycle regulation 22% (7/32) 5.15E−11
Cell cycle start of DNA replication in
early S-phase
19% (6/32) 3.79E−09
dCTP/dUTP metabolism 8% (6/75) 7.37E−07
Cell cycle role of SCF complex in cell
cycle regulation
14% (4/29) 6.82E−06
Cell cycle sister chromatid cohesion 14% (3/22) 1.13E−04
76 Downregulated SA-miRNA gene targets
Pathway maps % Regulated by
SA-miRNAs
p-value
Cell cycle role of APC in cell cycle regulation 16% (5/32) 1.26E−06
Folic acid metabolism 9% (5/53) 1.63E−05
DNA damage ATM/ATR regulation of G1/S
checkpoint
13% (4/32) 3.98E−05
Cell cycle ESR1 regulation of G1/S transition 12% (4/33) 4.51E−05
Cell cycle chromosome condensation in
prometaphase
14% (3/21) 2.68E−04
ce between early passage and late passage hMSCs were selected. These lists were then
lysed using Metacore from Genego.
g only gene targets of the 12 SA-miRNAS and biological pathways maps analysed using
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commonly deregulated in cancers [45,46] reﬂecting their importance
in regulation of cell proliferation processes. Alterations in these
signalling pathways could therefore be beneﬁcial to the establishment
of a senescent cell phenotype. The theoretical regulation of these
processes by the SA-miRNAs demonstrates further mechanisms by
which SA-miRNAs can cause the complex signalling pathway changes
required to induce senescence.
Two further pathways associated with gene expression increases
that could be regulated by the SA-miRNAs involve EGFR and the
ERBB family. As previously discussed, regulating signalling from the
ERBB family of tyrosine kinases is an important step in senescence
induction due to their role in the regulation of cellular prolifera-Fig. 6. SA-miRNA regulation of transcription and the role of AP1 in regulation of cellular me
show an object that can be regulated by a SA-miRNAwith thermometer numbering correspo
multiple SA-miRNAs. Green arrows represent positive, red negative and grey unspeciﬁed i
B=binding; Tr=transcriptional regulation, Cm=covalent modiﬁcation, T=transformationtion. The presence of this map demonstrates that SA-miRNAs are a
potential regulatory mechanism of these pathways during drug
induced replicative senescence as well as natural replicative
senescence.
The remaining pathway associated with increased gene target
expression is involved with changes in metabolism regulated by the
transcription factor AP-1. Closer inspection of the SA-miRNA targets
on this map (Fig. 6) highlights the role of AP-1 in regulation of p21 and
the apoptosis molecules c-fos and FASR. The involvement of c-fos and
FASR in pathways regulated by the SA-miRNAs has been highlighted
earlier in this study. This demonstrates that regulation of the diverse
cellular proliferation and apoptosis signalling pathways affected by
these molecules is an important step in senescence establishment,tabolism pathway biological map during drug induced senescence. Red thermometers
nding to that seen in Table 1. Multiple thermometers denote that the object is a target of
nteractions. Boxes on lines denote the type of regulation where P=phosphorylation;
and Z=catalysis.
Table 5
20 Differentially expressed genes upon induction of oncogene induced senescence
highlighted by Kuilman et al.
Gene name Regulating SA-miRNAs
C20ORF26 hsa-miR-369-5P (2), hsa-miR-29c (1),
hsa-miR-499 (3), hsa-miR-34b (1), hsa-miR-34c (2)
CD55 hsa-miR-29c (1), hsa-miR-34b (2), hsa-miR-34c (3)
CD9
CPE
FAM131A
FAM43A hsa-miR-371 (1)
GABRA2
GEM
GMFG hsa-miR-369-5P (1)
IL6 hsa-miR-499 (1), hsa-miR-216 (1), hsa-miR-371 (1)
IQGAP2
ITGA2
ITPKA
NR4A2
PCNX
PECAM1
PTGES hsa-miR-371 (1)
RPS6KA5
TESC hsa-miR-20a (1)
VGF
Also shown are the SA-miRNAs that can theoretically regulate 7 of these genes, brackets
show the number of theoretical 3′UTR binding sites that each SA-miRNA has for that
gene.
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induced. SA-miRNA regulation could therefore provide a mechanism
by which the absolute levels and timings of these signals can be
controlled.
The biological pathway map analysis of the decreases in gene
expression for telomerase inhibited cells returned results very similar
to that of the down-regulated genes in natural replicative senescence.
Four of the 5 maps are involved with the regulation of various aspects
of the cell cycle including the role of APC, the DNA damage response
checkpoint, regulation of ESR1 and chromosome condensation in
prometaphase (Table 4B). As with the cell cycle pathways seen in
replicative senescence, the regulation of cell cycle following telomer-
ase inhibition would be a critical step in senescence induction.
Targeting these multiple pathways to cell cycle control gives SA-
miRNAs comprehensive regulation of the process.
The remaining map is involved with metabolism of folic acid. As
previously discussed, changes in metabolism will be required in cells
undergoing senescence. However, this may also reﬂect metabolic
changes involved in the metabolism of BIBR1532, independent of
senescence, that the SA-miRNAs are also able to regulate. The ability of
SA-miRNAs to target not just the down-regulation cell cycle aspects of
senescence but also the metabolic changes demonstrates the
ﬂexibility and complexity of their action.
Looking at the pathway analysis of both replicative and drug
induced senescence shown in Table 4, highlights the fact that the
down-regulated pathways in both cases are cell cycle and metabolism
related whilst the up-regulated pathways differ between the two
stimuli. However, looking at the functions of the up-regulated
pathways in both cases reveals a common apoptosis regulatory signal.
Cells in replicative senescence appear to be signalling apoptosis
survival through FAS and TNFR1 pathways or in a p53 dependant
mannerwhereas the telomerase inhibited cells are using the actions of
Activin A and PTEN for this purpose. Thus the SA-miRNAs are
potentially using different cellular mechanisms by which to achieve
the same goal. The SA-miRNA regulation of the cellular signals behind
drug induced and natural replicative senescence are therefore stimuli
speciﬁc whilst remaining focused towards the common outcome of
creating the complex senescent cell phenotype.
3.3. SA-miRNA regulation of oncogene induced senescence emphasises
the importance of inﬂammatory signals in senescence
Telomere erosion leading to the activation of DNA damage
signalling cascades is not the only method of senescence induction.
Oncogene induced senescence (OIS) can be caused upon either the
loss of tumour suppressor genes like PTEN [47] or activation of
oncogenes such as MEK, RAS and BRAFE600 [48–50]. Recent evidence
suggests that senescence induction by these stimuli is dependent
upon IL-6 mediated inﬂammatory responses without which the cells
bypass senescence and continue proliferating [3]. The same study also
used gene expression microarrays to examine differentially expressed
genes between cells that bypass and cells that undergo OIS, revealing a
signature of 20 genes shown in Table 5. Seven of these genes,
including IL-6, can theoretically be regulated by SA-miRNAs.
Due to the small size of the initial signature, and hence the small
number of target genes, analysis of the biological pathways underlying
the SA-miRNA regulation was not statistically feasible. However, the
SA-miRNAs regulate nearly 30% of the OIS signature revealed by
Kuilman et al., including the key molecule IL-6 (Table 5). This may
demonstrate the principle that large numbers of gene alterations are
not always required for senescence induction, just well targeted ones.
Themultiple regulation of 3 of the genes in particular (C20orf26, CD55
and IL6) by the SA-miRNAs may show that within this signature these
genes require the strictest regulation to ensure the successful
induction of senescence, although further validation is required to
test this theory.Our analysis of differentially expressed genes during oncogene
induced senescence, although limited by the size of gene list, still
highlights the potential of SA-miRNAs to regulate key molecules
required for this form of senescence induction. Furthermore the
regulation of inﬂammatory networks shown in this study to be key to
senescence induction was also highlighted during our analysis of
replicative senescence. This common regulation of pro-inﬂammatory
genes in response to 2 different senescence stimuli by SA-miRNAs is
suggestive of its importance in senescence as a whole.
3.4. Regulation of stress induced senescence by SA-miRNAs transcends
treatment type to control core senescence processes
Senescence can also be induced by many different types of cellular
stress such as UV-B [51], hydrogen peroxide [52], tert-butylhydroper-
oxide (t-BHP) or ethanol exposure [53]. Pascal et al. used a
combination of differential display RT-PCR and low density DNA
arrays to investigate genes involved in senescence induction by
ethanol or t-BHP [2]. They revealed signatures of genes increasing and
decreasing in expression for both ethanol and t-BHP, many of which
overlapped. Table 6 highlights the potential of the SA-miRNAs as
regulators of stress induced senescence by both treatments. 75% of the
genes theoretically regulated by SA-miRNAs overlap between the two
treatment types. This may suggest that these target genes are those
that are core to senescence induction by SA-miRNA regulation.
Of all the overlapping genes shown in Table 6 four have roles in
regulation of the actin cytoskeleton, namely ARHGAP24, ARPC2,
MACF1 and S100A4 [54,55,56]. In our previous analysis cytoskeletal
remodelling has always been associated with genes showing
increased expression levels. Here however two of the molecules,
ARHGAP24 and ARPC2 show decreased expression. This may therefore
represent speciﬁc molecules that require negative regulation in the
context of stress induced senescence. Alternatively this may represent
down-regulation of genes required to create the necessary senes-
cence-associated cytoskeletal alterations. This demonstrates the
potential of SA-miRNAs to regulate similar processes through different
mechanisms dependant on stimuli.
Cell cycle regulation has in both replicative and drug induced
senescence been strongly negatively regulated. Two of the over-
lapping down-regulated genes, RAD17 and CDC37L1 (Table 6),
Table 6
SA-miRNA targets showing alterations in gene expression after stress induced
senescence by either tert-butylhydroperoxide (t-BHP) or Ethanol (EtOH) and the
direction of their alteration, blank cells infer no effect
Gene Effect of t-BHP
treatment
Effect of ETOH
treatment
Regulating SA-miRNAs
ARHGAP24 Down Down hsa-miR-499 (2)
ARPC2 Down Down hsa-miR-217 (2)
RAD17 Down Down hsa-let-7f (3)
CDC37L1 Down Down hsa-miR-20a (2), hsa-miR-34b (1),
hsa-miR-499 (2), hsa-miR-34c (1)
EWSR1 Down Down hsa-miR-20a (1)
PHGDH Down Down hsa-miR-34a (2), hsa-miR-34c (2)
MACF1 Up Up hsa-miR-369-5p (2)
RPS12 Up Up hsa-miR-369-5p (2)
LOXL2 Up Up hsa-miR-29c (1)
S100A4 Up Up hsa-miR-499 (2)
SLC35A5 Up Up hsa-miR-371 (1)
EEF1A1 Up Up hsa-miR-34c (1)
TBRG4 Up hsa-miR-34c (1)
KPNB1 Up hsa-miR-29c (1)
TMSB10 Up hsa-miR-499 (1)
C21orf34 Up hsa-miR-34b (2), hsa-miR-34c (1)
Also shown is the SA-miRNAs that can theoretically regulate these genes, brackets show
the number of theoretical 3′UTR binding sites that each SA-miRNA has for that gene.
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cycle. RAD17 speciﬁcally is involved in cell cycle arrest caused by DNA
damage signalling [57]. The DNA damage caused by reactive oxygen
species in cellular senescence may therefore be activating similar
mechanisms of senescence induction as that seen in replicative
senescence. These gene targets highlight the fact that the SA-miRNAs
are able to induce similar mechanisms through the use of stimuli
speciﬁc target genes. The ﬂexibility of the SA-miRNA mechanism of
action allows them to remain speciﬁc enough for a cell to respond to a
particular stimuli whist general enough to focus pathway changes in
those cells to create the senescent cell phenotype.
Two of the overlapping genes, EWSR1 and LOXL2, have previous
evidence of senescence association. The EWS fusion protein has
recently been reported as a repressor of senescence [58] and therefore
its down-regulation by SA-miRNAS would provide a mechanism by
which to prevent it inhibiting senescence induction. LOXL2 however
has been used as a marker of senescent cells due to its increased
expression during senescence [59]. These senescent associated genes
can theoretically be regulated by SA-miRNAs and this may therefore
present a mechanism bywhich their roles in senescence induction are
controlled.
The remaining overlapping genes may still have roles in senes-
cence. These genes may be involved in senescence induction through
previously identiﬁed or potentially novel unidentiﬁed pathways,
which analysis of the individual gene function does not elucidate.
Their inclusion into larger data sets of potential senescence associated
genes for systems biology analysis may help to elucidate their role.
MiRNA regulation of stress induced senescence can therefore be
seen to potentially transcend treatment type and incur changes in core
senescence genes. Furthermore regulation of additional treatment
speciﬁc genes gives SA-miRNAs the potential to alter diverse cellular
pathways required to respond to different stimuli.
4. SA-miRNAs regulate common cellular mechanisms regardless
of stimuli
The regulation of different senescence induction stimuli by
miRNAs varies as shown in Table 3. In this study we have seen
evidence of the potential SA-miRNAs regulation of core sets of
senescence genes regardless of inductionmechanism. Our analysis has
highlighted common up-regulation of apoptosis signalling and pro-
inﬂammatory gene regulation targeted by SA-miRNAs betweendifferent senescence stimuli. We have also seen SA-miRNA targeted
down-regulation of cell cycle processes across the induction mechan-
isms. This evidence taken in combination with the large degree of
overlap between treatment types in stress induced senescence is
suggestive of key cellular changes that the SA-miRNAs can facilitate
during senescence induction. To our knowledge, this is the ﬁrst report
of predicted miRNA regulation of common pathways regardless of
senescence stimulus.
The fact that 2 SA-miRNAs, hsa-miR-499 and hsa-miR-34c, can
regulate all of the senescence types we have examined takes this
concept one step further and may suggest that these particular SA-
miRNAs act as master regulators for senescence induction. Alterations
in different biological signalling pathways by the remaining 10 SA-
miRNAs could then tailor the cellular response to suit the alterations
required by speciﬁc stimuli. This hypothesis requires further labora-
tory validation, however the fact that both miRNAs already have
experimental evidence to show they are senescence regulators adds
some weight to the theory.
5. Conclusions
In this study we have used pathway mapping and theoretical gene
target identiﬁcation to create a biological framework by which to test
the relevance of miRNAs in senescence induction. We have shown not
only that miRNAs can potentially regulate genes previously seen to be
involved in senescence but also regulate larger pathway alterations,
such as cell cycle and cytoskeletal remodelling, that would logically be
required to create the complex phenotype of the senescent cell.
Commonly regulated pathways and cellular mechanisms between the
senescence stimuli also demonstrate the potential of SA-miRNAs to
regulate a core set of pathway modiﬁcations regardless of senescence
induction mechanism. Furthermore, we have identiﬁed stimulus
speciﬁc pathways by which SA-miRNAs can regulate apoptosis
survival signals in cells undergoing drug induced or natural replicative
senescence. The identiﬁcation of miR-499 and miR-34c as common
regulators of all senescence stimuli we have studied may highlight
their potential as future drug targets for senescence induction and
further investigation of their role in regulation of the senescence
phenotype certainly warrants further investigation.
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